Central Regional Employees Benefit Fund v. Pfizer, Inc

Court

District Court, D. New Jersey (D.N.J.)
Official Court Website →

Docket number

3:12-cv-04153

Nature of suit

410 Antitrust
Claims of unlawful restraint of trade, monopolization, or anticompetitive conduct under the Sherman and Clayton Acts.

Jurisdiction

Federal question

Date filed

07/06/2012

Date terminated

03/04/2016

1,189 Antitrust cases in this court are indexed here.

Parties

• plaintiff · Central Regional Employees Benefit Fund · 2 cases
• defendant · Pfizer Inc Pharmaceuticals & Biotechnology · 12528 cases

Part of a Larger Litigation Pattern

This is one of 12,529 Antitrust cases in our index naming PFIZER INC — a possible mass-tort or coordinated-litigation cluster.

• Pfizer Inc v. Novo Nordisk A/S
  District Court, D. DelawareFiled 11/03/2025
• Cesar Castillo, LLC v. Pfizer, Inc
  District Court, D. New JerseyFiled 05/22/2020
• Cvs Pharmacy, Inc v. Pfizer Inc
  District Court, D. New JerseyFiled 08/03/2018
• Pfizer Inc v. Johnson & Johnson
  District Court, E.D. PennsylvaniaFiled 09/20/2017
• Cesar Castillo, Inc v. Pfizer, Inc
  District Court, E.D. VirginiaFiled 07/08/2015
• Allied Services Division Welfare Fund v. Pfizer, Inc
  District Court, E.D. VirginiaFiled 01/20/2015

About Antitrust Lawsuits

Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.

Frequently Asked Questions

What is Central Regional Employees Benefit Fund v. Pfizer, Inc?

Central Regional Employees Benefit Fund v. Pfizer, Inc is a federal antitrust lawsuit filed on 07/06/2012 in the District Court, D. New Jersey. The case was terminated on 03/04/2016. Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.

What type of case is this?

It is classified as “Antitrust” under the federal nature-of-suit system. Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.

What court is the case in?

The case is in the District Court, D. New Jersey, docket number 3:12-cv-04153.

When was the case filed?

Central Regional Employees Benefit Fund v. Pfizer, Inc was filed on 07/06/2012. It was terminated on 03/04/2016.